Trial Profile
A prospective double blind randomised trial of nebivolol in prevention of anthracycline-induced cardiomyopathy in breast cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Cardiomyopathies
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.